The Market Reports

Synopsis
The global market for Medical Silicone Vasculature was estimated to be worth US$ 26.1 million in 2024 and is forecast to a readjusted size of US$ 58.6 million by 2031 with a CAGR of 12.0% during the forecast period 2025-2031.
Medical Silicone vasculature refers to models or replicas of blood vessels (arteries, veins, capillaries) created using silicone materials. These models are designed to replicate the structure, elasticity, and physical properties of human or animal vascular systems. They are primarily used in medical education, surgical training, device testing, and research to simulate realistic vascular environments.
The major global manufacturers of Medical Silicone Vasculature include United Biologics, TrandoMed, BDC Laboratories, Elastrat, Mentice, Preclinic Medtech, FAIN-Biomedical, Shelley Medical, MedScan3D, Medical Implant Mechanics, Vascular Labs, Swiss Vascular, etc. In 2024, the world's top three vendors accounted for approximately 54.00% of the revenue.
Globally, the medical silicone vasculature market is competitive, with both established medical device companies and newer startups involved in the development and commercialization of silicone-based vascular products. And some enterprises, like United Biologics, TrandoMed, BDC Laboratories, etc. are well-known for the wonderful performance of their Medical Silicone Vasculature and related services. At the same time, United Biologics occupied 25% sales market share in 2024, is remarkable in the global Medical Silicone Vasculature industry because of their market share and technology status of Medical Silicone Vasculature.
The sale areas of Medical Silicone Vasculature in various regions of the world are mainly distributed in North America, Europe, Asia-Pacific.
This report aims to provide a comprehensive presentation of the global market for Medical Silicone Vasculature, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Silicone Vasculature by region & country, by Type, and by Application.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Medical Silicone Vasculature cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Medical Silicone Vasculature market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Silicone Vasculature.
Market Segmentation
By Company
United Biologics
TrandoMed
BDC Laboratories
Elastrat
Mentice
Preclinic Medtech
FAIN-Biomedical
Shelley Medical
MedScan3D
Medical Implant Mechanics
Vascular Labs
Swiss Vascular
Segment by Type
Neuro
Cardiac
Abdominal
Peripheral
Others
Segment by Application
Medical Education
Professional Training
Marketing
R&D
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Silicone Vasculature manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Silicone Vasculature in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Silicone Vasculature in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index